Sona Nanotech Inc. (SNANF)
- Previous Close
0.2100 - Open
0.2100 - Bid 0.2020 x --
- Ask 0.2160 x --
- Day's Range
0.2100 - 0.2100 - 52 Week Range
0.1590 - 0.2750 - Volume
2,500 - Avg. Volume
10,526 - Market Cap (intraday)
23.633M - Beta (5Y Monthly) 1.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Jun 27, 2025 - Jul 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.
www.sonanano.com--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: SNANF
View More
Performance Overview: SNANF
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNANF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNANF
View MoreValuation Measures
Market Cap
23.20M
Enterprise Value
22.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
19.39
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-65.06%
Return on Equity (ttm)
-196.80%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.86M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.45M
Total Debt/Equity (mrq)
24.23%
Levered Free Cash Flow (ttm)
-550.25k